Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...
Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
StockStory.org on MSN2d
Regeneron’s (NASDAQ:REGN) Q4 Sales Top Estimates, Stock Soars
Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results , with sales up 10.3% year on year to $3.79 billion. Its ...
REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and ...
Yahoo20d
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
“All of this health information—their health records and the biospecimens—are coming to us de-identified,” Regeneron spokesperson Ella Campbell tells Fortune. “We have all of these data ...
MarketWatch23d
Regeneron Working with Truveta's Network to Extend Database
The center will have exclusive rights to perform all research-related sequencing on samples collected under the collaboration, Regeneron said. Both Regeneron and Truveta will use the data to ...
Business Insider24d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
The Regeneron Genetics Center ® has sequenced nearly three million people to date, all with deidentified linked healthcare records. A newly announced strategic collaboration with Truveta ...
FiercePharma23d
JPM25: Regeneron CEO says it needs more 'arrows in its quiver' as Eylea HD sales fall short
Regeneron also hopes for a retinal vein occlusion ... We know the retinal community very well. But we didn’t have all the tools necessary to optimize Eylea HD.” Roche's Vabysmo will rise ...
Nasdaq24d
Regeneron and Truveta Announce Strategic Collaboration for the Truveta Genome Project, Aiming to Expand Genetic Database and Accelerate Drug Discovery
Regeneron collaborates with Truveta to expand ... up to ten million additional de-identified patient volunteers, all with linked electronic health records (EHRs). This novel resource is designed ...
Yahoo Finance24d
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
Regeneron pledged $119.5m while Illumina is ... of the party’s pledge to fix the National Health Service (NHS). The All of Us Research Program (AOR) from the National Institutes of Health ...
Newsday28d
Regeneron Science Talent Search scholars: Long Island has 49 semifinalists, more than any other U.S. region
“All of us have been working together for pretty ... The contest has been sponsored since 2017 by Regeneron Pharmaceuticals Inc., a Tarrytown-based biotechnology company. Before Regeneron ...